Gene · 51192
Papers1,450
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,450
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel aggregation framework based on complex n,m-rung orthopair fuzzy aczel-alsina operators for renewable energy decision-making. | Sci Rep | 2025 | 41174013 | PubTator, text mining | PubMed |
| Fingerprint stability of the oil biomarker hopanes and steranes in different aquatic mediums. | J Chromatogr A | 2025 | 40929929 | PubTator, text mining | PubMed |
| Insights into type IX secretion from PorKN cogwheel structure bound to PorG and attachment complexes. | Nat Commun | 2025 | 40830366 | PubTator, text mining | PubMed |
| Oncogenic CMTM6 drives M2a macrophages formation and fuels cervical cancer progression. | Front Immunol | 2025 | 40761779 | PubTator, text mining | PubMed |
| Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study. | Int J Mol Sci | 2025 | 40724958 | PubTator, text mining | PubMed |
| Individualized diagnosis of rheumatoid arthritis: A rank-based qualitative T cell-related signature. | PLoS One | 2025 | 40569958 | PubTator, text mining | PubMed |
| Inhibiting CMTM4 reverses the immunosuppressive function of myeloid-derived suppressor cells and augments immunotherapy response in cervical cancer. | J Immunother Cancer | 2025 | 40514067 | PubTator, text mining | PubMed |
| Exosomal CMTM4 Induces Immunosuppressive Macrophages to Promote Ovarian Cancer Progression and Attenuate Anti-PD-1 Immunotherapy. | Adv Sci (Weinh) | 2025 | 40433989 | PubTator, text mining | PubMed |
| Understanding temperature-rain data using ID3 based concept reduction technique in FCA. | Sci Rep | 2025 | 40414983 | PubTator, text mining | PubMed |
| Chemokines-like factor 1 as a serological biomarker in relation to disease severity and 90-day prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study. | Neurosurg Rev | 2025 | 40394360 | PubTator, text mining | PubMed |
| Serum miR-130a-3p and miR-326: Correlation with Airway Inflammation and Prognostic Implications in Pediatric Bronchial Asthma. | J Asthma Allergy | 2025 | 40270985 | PubTator, text mining | PubMed |
| Peptidomic profiling of mesenchymal stem cell-derived extracellular vesicles and anti-inflammatory activity of degraded peptides. | Int Immunopharmacol | 2025 | 40096816 | PubTator, text mining | PubMed |
| CKLF1 disrupts microglial efferocytosis following acute ischemic stroke by binding to phosphatidylserine. | Cell Death Differ | 2025 | 40057593 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Esculetin facilitates post-stroke rehabilitation by inhibiting CKLF1-mediated neutrophil infiltration. | Acta Pharmacol Sin | 2025 | 39112771 | PubTator, text mining | PubMed |
| The sufficiency-based, the de-growth, and the official - Critical remarks of the electricity chapter of the Hungarian national energy and climate plan based on a comparison to alternative scenarios. | Heliyon | 2024 | 39553585 | PubTator, text mining | PubMed |
| Dihydromyricetin treats pulmonary hypertension by modulating CKLF1/CCR5 axis-induced pulmonary vascular cell pyroptosis. | Biomed Pharmacother | 2024 | 39461017 | PubTator, text mining | PubMed |
| Intelligent Method of Identifying the Nonlinear Dynamic Model for Helicopter Turboshaft Engines. | Sensors (Basel) | 2024 | 39409532 | PubTator, text mining | PubMed |
| Auditing road safety achievement using MEREC-ARAS-QBKM model: an empirical study for APEC member economies. | Sci Rep | 2024 | 39367074 | PubTator, text mining | PubMed |
| NERD-seq: a novel approach of Nanopore direct RNA sequencing that expands representation of non-coding RNAs. | Genome Biol | 2024 | 39198865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51192/papers?page=2